As it turns out, Cyfra211 showed higher sensitivity (72.4–75.9%) in diagnosis of squamous cell carcinoma than SCCAg, CEA, and CTAPIII/CXCL‐7, consistent with previous reports. The gene discussed is PPBP; the disease is squamous cell carcinoma.